Published on
Emergency and Acute Medicine – Spontaneous Abortion (Early Pregnancy Loss)


Overview and Definitions
Spontaneous abortion refers to the unintentional termination of an intrauterine pregnancy before 20 weeks of gestation. It is also commonly termed early pregnancy loss or miscarriage. This condition occurs in approximately 15–20% of clinically recognized pregnancies, making it the most frequent complication of early pregnancy. Vaginal bleeding during the first trimester is reported in nearly one-quarter of pregnant patients, and about half of these cases ultimately result in pregnancy loss.


Several clinical subtypes are recognized. Threatened abortion presents with vaginal bleeding and a closed cervical os in the presence of a viable intrauterine pregnancy; approximately half of these patients will go on to miscarry. Inevitable abortion is characterized by bleeding with an open cervical os before expulsion of products of conception (POC). Incomplete abortion involves partial expulsion of POC with retained tissue and ongoing bleeding, while complete abortion describes full expulsion of all POC with subsequent closure of the cervical os. Missed abortion occurs when fetal demise is present without uterine activity or expulsion. Septic abortion is complicated by intrauterine infection, and recurrent spontaneous abortion is defined as three or more consecutive pregnancy losses.


Etiology and Risk Factors
The most common cause of spontaneous abortion is fetal chromosomal abnormality. Other contributing factors include uterine structural abnormalities and a variety of maternal risk factors. These include advanced maternal or paternal age, increased parity, smoking, alcohol or cocaine use, conception within a short interval after delivery, and chronic maternal illnesses such as poorly controlled diabetes, autoimmune disease, or celiac disease. Extremes of maternal body mass index, intrauterine devices, multiple prior elective abortions, and prior pregnancy losses also increase risk.
Maternal infections—including bacterial vaginosis, sexually transmitted infections, viral illnesses, parasitic infections, and TORCH pathogens—are important contributors. Certain medications, toxins, and uterine abnormalities such as fibroids, adhesions, or congenital malformations further predispose to pregnancy loss.


Clinical Presentation
Patients commonly present with vaginal bleeding and may report abdominal pain or cramping. Important historical details include last menstrual period, gestational age, obstetric history, prenatal care, and known risk factors. Bleeding should be quantified by duration and number of pads used, and patients should be asked about passage of clots or tissue. Symptoms such as dizziness or syncope may suggest significant blood loss.


Physical Examination
Assessment begins with evaluation of hemodynamic stability. Because blood volume is increased during pregnancy, particularly toward the end of the first trimester, patients may lose a substantial amount of blood before abnormal vital signs appear. Pelvic examination is essential to assess cervical dilation, amount of bleeding, and presence of POC. Adnexal tenderness or signs of peritoneal irritation raise concern for ectopic pregnancy. A bimanual examination helps estimate uterine size, which correlates with gestational age.


Essential Workup
Confirmation of pregnancy and assessment of gestational age and viability are central to evaluation. Imaging and laboratory studies are guided by clinical stability and suspected diagnosis.


Diagnostic Tests and Interpretation
Pregnancy is confirmed with urine or serum testing; most urine tests become positive at low β-hCG levels early in gestation and may remain positive for weeks after pregnancy loss. Laboratory evaluation includes complete blood count, rapid hemoglobin assessment, blood type and Rh status, and quantitative β-hCG levels. Type and cross-match are required for patients with active bleeding or anemia. Any expelled tissue should be sent for pathologic confirmation.
Transvaginal ultrasound is the preferred imaging modality in early pregnancy and can identify a gestational sac by approximately five weeks and cardiac activity by about six and a half weeks. Transabdominal ultrasound detects findings later. The discriminatory β-hCG zone defines the level at which a normal intrauterine pregnancy should be visualized and helps differentiate early pregnancy loss from ectopic pregnancy.


Differential Diagnosis
In patients with a positive pregnancy test and vaginal bleeding, alternative diagnoses include ectopic pregnancy, molar pregnancy, pregnancy of unknown location, cervicitis, subchorionic hemorrhage, septic abortion, and trauma. In later pregnancy, placental abruption and placenta previa must be considered.


Initial Stabilization and Emergency Management
Prehospital and early emergency department care focuses on monitoring vital signs, providing oxygen, establishing intravenous access, and treating hypovolemia. Unstable patients require aggressive resuscitation with large-bore IV access, crystalloid infusion, and transfusion of packed red blood cells if they fail to stabilize. Gynecologic consultation is urgent in unstable patients, as ruptured ectopic pregnancy must always be excluded.


Definitive Management by Clinical Type
Threatened abortion is managed conservatively with pelvic rest and close obstetric follow-up. Patients without documented cardiac activity early in pregnancy require serial β-hCG testing to assess viability and exclude ectopic pregnancy.
Inevitable and incomplete abortions may be managed expectantly, medically with misoprostol, or surgically with dilation and curettage. Surgical management reduces the risk of unplanned admissions and transfusion and allows pathologic confirmation of POC.
Complete abortion typically requires no intervention beyond observation, although uterotonic agents may be used if bleeding persists.
Missed abortion carries a risk of disseminated intravascular coagulation when fetal tissue is retained for several weeks, necessitating laboratory monitoring and specialist follow-up. Management options include expectant, medical, or surgical approaches based on patient preference and clinical stability.


Medications
Rh-negative patients require Rho(D) immunoglobulin to prevent alloimmunization, with dosing based on gestational age. Misoprostol is used for medical management of pregnancy loss under obstetric guidance. Uterotonic agents such as oxytocin or methylergonovine may be required to control heavy bleeding.


Disposition and Follow-Up
Admission is required for suspected ectopic pregnancy, hemodynamic instability, significant anemia, septic abortion, disseminated intravascular coagulation, or suspected gestational trophoblastic disease.
Stable patients may be discharged after appropriate treatment or observation, with pain control and close obstetric follow-up. Clear return precautions are essential.


Discharge Counseling and Support
Patients should be advised to return immediately for worsening bleeding, dizziness, fever, or increasing pain. Pelvic rest is recommended during active bleeding. Emotional support and reassurance are crucial, emphasizing that early pregnancy loss is common and not the result of patient actions.


Clinical Pearls and Pitfalls
Always maintain a high index of suspicion for ectopic pregnancy in early pregnancy bleeding. Significant blood loss can occur despite initially normal vital signs, and careful reassessment is essential.


Picture
0 Comments